Form 4: DSS, Inc. Reports Changes in Beneficial Ownership of Impact Biomedical Inc. Shares

DSS, Inc. reports transactions involving Impact Biomedical Inc. (IBO) common stock, including acquisitions and disposals, affecting its beneficial ownership.

Summary

• DSS, Inc. filed a Form 4 detailing changes in its beneficial ownership of Impact Biomedical Inc. (IBO) common stock.
• On December 2, 2024, DSS, Inc. disposed of 20 shares of common stock at a price of $2.9.
• On March 20, 2025, DSS, Inc. acquired 200 shares of common stock at a price of $1.55.
• Also on March 20, 2025, DSS, Inc. disposed of 53,280 shares of common stock at a price of $4.68.
• Following these transactions, DSS, Inc. indirectly owns 53,080 shares through Sentinel Brokers Company, Inc., 1,345,482 shares through DSS BioHealth Security, Inc., 166,600 shares through DSS Securities, Inc., and 166,600 shares through DSS BlockChain Security, Inc.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing. The sentiment is neutral as it simply reports transactions.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders and significant shareholders.

Stakeholder Impact

• The transactions may influence investor perception of Impact Biomedical Inc.'s stock.

Key Dates

Keywords

beneficial ownership, Impact Biomedical Inc., IBO, DSS, Inc., Form 4, securities transactions, common stock, Sentinel Brokers Company, Inc., DSS BioHealth Security, Inc., DSS Securities, Inc., DSS BlockChain Security, Inc.